A recent study conducted by researchers from the University of British Columbia Okanagan and the University of Exeter has shed light on the potential of ketamine in treating a range of mental health disorders, including depression, PTSD, bipolar disorder, and eating disorders. By analyzing over 150 global studies on sub-anesthetic doses of ketamine, the researchers discovered significant anti-depressant and anti-suicidal properties. This breakthrough could pave the way for innovative and more effective mental health treatments.

In an unprecedented move against the opioid epidemic, Kentucky has launched a groundbreaking $42 million program to probe the potential of ibogaine. This naturally-occurring psychedelic has shown considerable promise in reducing dependency on opioids.

Neuralink, the brain-implant company founded by visionary entrepreneur Elon Musk, has reached a significant milestone with the approval of its first-in-human clinical trial by the U.S. Food and Drug Administration (FDA). This breakthrough represents a crucial step forward for Neuralink, following previous challenges in obtaining regulatory clearance for its groundbreaking technology. With the FDA's green light, Neuralink is now one step closer to fulfilling its mission of utilizing brain implants to address a wide range of conditions and potentially unlock extraordinary capabilities such as web browsing and telepathy.

With The regulatory framework of measure 109 now in place, the start of 2023 means that Oregon is beginning to accept applications for licenses to operate in the new psychedelic industry.

Enthea, a provider of psychedelic healthcare insurance plans, declared that it will expand its services into 40 markets across the US in 2023 with the goal of making workplace benefits for psychedelic-assisted therapies reasonable, equitable, and available.

Psychonauts waited for over an hour outside a Portland Mushroom Supplement Store, with lines wrapping around the building, to get their hands on some psychedelic mushrooms before they sold out.

Colorado Votes on Decriminalizing the Possession, Storing, Using, Processing, Transporting, Purchasing, Obtaining, or INGESTING NATURAL MEDICINE FOR PERSONAL USE AND EVEN GIVING AWAY NATURAL MEDICINE FOR PERSONAL USE WITHOUT REMUNERATION TO A PERSON OR PERSONS TWENTY-ONE YEARS OF AGE OR OLDER!

Democratic senator, Cory Booker, and Republican Rand Paul collaborated on a new version of the “Right to Try” bill called the “Right To Try Clarification Act”. The Right to Try Clarification Act is a proposed law that would clarify the right of terminally ill patients to access experimental therapies, such as psychedelic-assisted therapy. This right is currently protected by a federal statute called the “Right to Try Act.”

Senator Scott Wiener’s Senate Bill 519, which decriminalizes the possession and personal use of certain psychedelic drugs will be voted on next year. San Francisco Supervisors Dean Preston and Hillary Ronen introduced legislation that would decriminalize use and possession of psilocybin mushrooms, LSD, MDMA, DMT, and Mescaline.

The Drug Enforcement Administration has reversed its decision to the scheduling proposal that would have placed five tryptamine hallucinogens, as identified in this proposed rule, in schedule I of the Controlled Substances Act.

In partnership with the newly founded Center for Psychedelic Drug Research and Education at The Ohio State University, Psychedemia 2022 will provide a rigorous interdisciplinary symposium for exchanging ideas, evaluating dominant perspectives, and critiquing current approaches to developing social frameworks for psychedelic use.

Red Light Holland Corp. based in the Netherlands, is partnering with Rapper Wiz Khalifa to launch MisterCap, A premium brand of magic mushrooms and truffles to the recreational market, along with mushroom-themed merchandise, decor, and tele-counseling services. This collaboration with Wiz Khalifa is to leverage the rapper’s significant social media presence and help grow the brand.

New Jersey Introduced a bill that would legalize the possession, home cultivation, ingesting, and gifting of psilocybin mushrooms for adults 21 and older to promote mental health and wellness

B.C.-based company, Optimi Health has harvested its first cultivation of psilocybin mushrooms at its Health Canada-licensed facilities in Princeton, B.C., positioning itself as a major player in the burgeoning psychedelic sector. According to Optimi's head cultivator, Todd Henderson, The $14-million venture consists of two 10,000-square-feet facilities with a combined total of 10 growing rooms that can produce approximately 2,000 kilograms of dried psilocybin mushrooms a month.

Unlimited Sciences in collaboration with Dr. Robin Carhart-Harris, will conduct an observational research study with a group of primarily female immigrants and refugees who will participate in an Ayahuasca ceremony in the hopes that the experience will help them heal from prior trauma. The study will engage licensed therapists and psychologists who are experienced with psychedelic therapy and Integration

'We Should Take This Seriously”

Elon Musk, Owner of Tesla, SpaceX, Boring Co. Starlink and Solar City, is the world’s richest man and outspoken eccentric innovator of “The Future”, who believes we need to ditch the pills and look at Psychedelics, Hallucinogens, and Entheogens like Mushrooms, LSD, and MDMA as a Serious Treatment for Mental Health and Expanding Human Consciousness.

Awakn Life Sciences Corp. , a psychedelic biotechnology company focused on researching, developing, and commercializing therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder, has announced on June 2nd that they have initiated a larger behavioral addiction study investigating ketamine as a treatment for Gambling Disorder.

A Maryland House of Delegates Committee recently held a hearing on creating a psychedelics access fund. The Post-Traumatic Stress Disorder and Traumatic Brain Injury Alternative Therapies Fund could give Maryland’s veterans access to psychedelics like psilocybin, MDMA, and ketamine to help them find relief.

Activists staged a demonstration outside of the Drug Enforcement Administration headquarters in Virginia, demanding that the agency allow terminally ill patients to access psilocybin therapy. The Protest was meant to call attention to DEA’s obstruction of Right to Try statutes at the federal and state level that patients and advocates say should facilitate legal use of psychedelics.

THE NATURAL MEDICINE HEALTH ACT OF 2022, Brings Colorado one step closer to Psychedelic Drug Decriminalization